Vencanna Ventures Inc. (CSE:VENI)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Jul 31, 2026, 9:30 AM EST
Vencanna Ventures Revenue
In the fiscal year ending April 30, 2026, Vencanna Ventures had annual revenue of $1.88M USD, down -53.14%. Vencanna Ventures had revenue of $488.88K in the quarter ending April 30, 2026, a decrease of -22.85%.
Revenue
$1.88M
Revenue Growth
-53.14%
P/S Ratio
0.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.11M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 1.88M | -2.13M | -53.14% |
| Apr 30, 2025 | 4.01M | - | - |
| Apr 30, 2024 | - | - | - |
| Dec 31, 2023 | 10.06M | -715.30K | -6.64% |
| Dec 31, 2022 | 10.77M | -3.37M | -23.82% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Adastra Holdings | 16.86M |
| RAMM Pharma | 1.89M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 57.34K |
| Genix Pharmaceuticals | 68.00 |
| Captor Capital | -5.05M |